| | DECEMBER 20249IN FOCUSHSBC is undergoing a shake-up in its senior leadership team, with several new appointments set to take effect from January 1, 2025, including a new CEO for the Middle East region. Selim Kervanci has been appointed CEO of the Middle East, pending regulatory approval, and will report to Surendra Rosha and David Liao, Co-CEOs of Asia and the Middle East.Kervanci has worked in regional roles for several years, has been on the MENAT ExCo for more than 10, and is currently CEO of HSBC Türkiye.After holding several senior risk leadership positions within HSBC, including Chief Risk Officer for Global Banking Markets, Commercial Banking, MENAT, and Europe, Richard Blackburn has been appointed Interim Group Chief Risk and Compliance Officer.Having joined HSBC in 2016, Blackburn most recently held the position of Global Head of Traded and Treasury Risk Management & Global Analytics. A successor to the role has yet to be appointed.Celine Herweijer, the Group Chief Sustainability Officer with HSBC, has stepped down from her role with effect from December 31, 2024. She has been credited for playing a role in advancing HSBC's Net Zero by 2050 program launched in 2020.Julian Wentzel, currently Head of Global Banking, MENAT, has been appointed Interim Group Chief Sustainability Officer and will report to Group CFO, Pam Kaur. L.E.K. Consulting, a global strategic consultancy, has bolstered its Healthcare Advisory practice in Asia by adding Hayato Akagawa. Based in Tokyo, Akagawa brings over 15 years of expertise, focusing on portfolio strategies, market access strategies, and sales model transformation in the healthcare and pharmaceutical sectors. His career includes senior positions at major industry players such as Janssen Pharmaceuticals and Pfizer and roles at investment bank Locust Walk and the Big Four consulting firm PwC.Before joining L.E.K. Consulting as a Principal, Akagawa served as Vice President at Locust Walk, where he developed and managed client relationships with major Japanese pharmaceutical companies, and as Director of Healthcare Advisory at PwC, where he led diverse projects, from portfolio strategy and market access to go-to-market models for new products, in various segments including rare disease, oncology and immunology.Akagawa also brings to L.E.K. Consulting a proven background in brand and portfolio management from his roles at Janssen Pharmaceuticals and Pfizer, where he managed and grew multi-billion yen portfolios and executed successful product launches."We're thrilled to welcome Hayato to the team," said Yuta Inokuchi, Head of Japan at L.E.K. Consulting. "His wealth of experience in healthcare consulting, coupled with his strategic vision for transforming commercial operations, makes him a strong asset to our clients and our team".L.E.K. Consulting was founded in 1983 by three former partners from Bain & Company. Strategy Consulting has offices around the world, its Tokyo office launched in 2002. HSBC RESHUFFLES SENIOR LEADERSHIP TEAM AND NAMES NEW CEO FOR THE MIDDLE EASTHAYATO AKAGAWA JOINS L.E.K. CONSULTING'S HEALTHCARE ADVISORY PRACTICE IN ASIA PACIFIC
< Page 8 | Page 10 >